Showing results (31-40 of 119) with videos related to

Sort By:
Pageof 12
The Journal of Investigative Dermatology|March 20, 2009
Differential effects of corticosteroids and pimecrolimus on the developing skin immune system in humans and miceSimone Meindl, Christine Vaculik, Josef G Meingassner, et al.
Urology|May 22, 2012
Circulating angiostatin, bFGF, and Tie2/TEK levels and their prognostic impact in bladder cancerTibor Szarvas, Tobias Jäger, Viktoria Laszlo, et al.
International Journal of Cancer|March 12, 2014
Prognostic value of tissue and circulating levels of IMP3 in prostate cancerTibor Szarvas, Stephan Tschirdewahn, Christian Niedworok, et al.
Cancer|September 17, 2010
Hypothyroidism in patients with renal cell carcinoma: blessing or curse?Manuela Schmidinger, Ursula M Vogl, Marija Bojic, et al.
Human Pathology|March 25, 2014
Enhanced stromal syndecan-1 expression is an independent risk factor for poor survival in bladder cancerTibor Szarvas, Henning Reis, Gero Kramer, et al.
BJU International|June 21, 2014
Docetaxel rechallenge after an initial good response in patients with metastatic castration-resistant prostate cancerStéphane Oudard, Gero Kramer, Orazio Caffo, et al.
Urologie (Heidelberg, Germany)|October 24, 2023
[Androgen deprivation therapy and cardiovascular morbidity in prostate cancer: a narrative review]Jakob Klemm, Markus von Deimling, Margit Fisch, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 5, 2002
Capecitabine in the treatment of metastatic renal cell carcinoma failing immunotherapyCatharina Wenzel, Gottfried J Locker, Manuela Schmidinger, et al.
Oncotarget|April 18, 2018
Analysis of hematological parameters as prognostic markers for toxicity and survival of 223Radium treatmentAsha Leisser, Marzieh Nejabat, Markus Hartenbach, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|June 8, 2001
Sequential Administration of Interferon-gamma, GM-CSF, and Interleukin-2 in Patients With Metastatic Renal Cell Carcinoma: Results of a Phase II TrialManuela Schmidinger, Guenther Steger, Catharina Wenzel, et al.
Pageof 12